Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Dec 6, 2022; 10(34): 12532-12542
Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12532
Figure 2
Figure 2 Rates of malignant, premalignant (in colon and rectum), and benign incidental focal hypermetabolic fluorine-18 fluorodeoxyglucose uptake in the colon/rectum, thyroid, and prostate. “ALL” indicates benign (39.4%) and malignant/premalignant (60.6%) lesions.